ID   PUR4_PSEAE              Reviewed;        1298 AA.
AC   Q9HXN2;
DT   11-JUL-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   02-DEC-2020, entry version 133.
DE   RecName: Full=Phosphoribosylformylglycinamidine synthase {ECO:0000255|HAMAP-Rule:MF_00419};
DE            Short=FGAM synthase {ECO:0000255|HAMAP-Rule:MF_00419};
DE            Short=FGAMS {ECO:0000255|HAMAP-Rule:MF_00419};
DE            EC=6.3.5.3 {ECO:0000255|HAMAP-Rule:MF_00419};
DE   AltName: Full=Formylglycinamide ribonucleotide amidotransferase {ECO:0000255|HAMAP-Rule:MF_00419};
DE            Short=FGAR amidotransferase {ECO:0000255|HAMAP-Rule:MF_00419};
DE            Short=FGAR-AT {ECO:0000255|HAMAP-Rule:MF_00419};
GN   Name=purL {ECO:0000255|HAMAP-Rule:MF_00419}; OrderedLocusNames=PA3763;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
CC   -!- FUNCTION: Phosphoribosylformylglycinamidine synthase involved in the
CC       purines biosynthetic pathway. Catalyzes the ATP-dependent conversion of
CC       formylglycinamide ribonucleotide (FGAR) and glutamine to yield
CC       formylglycinamidine ribonucleotide (FGAM) and glutamate.
CC       {ECO:0000255|HAMAP-Rule:MF_00419}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + L-glutamine + N(2)-formyl-N(1)-(5-phospho-beta-D-
CC         ribosyl)glycinamide = 2-formamido-N(1)-(5-O-phospho-beta-D-
CC         ribosyl)acetamidine + ADP + H(+) + L-glutamate + phosphate;
CC         Xref=Rhea:RHEA:17129, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29985, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:58359, ChEBI:CHEBI:147286, ChEBI:CHEBI:147287,
CC         ChEBI:CHEBI:456216; EC=6.3.5.3; Evidence={ECO:0000255|HAMAP-
CC         Rule:MF_00419};
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; 5-
CC       amino-1-(5-phospho-D-ribosyl)imidazole from N(2)-formyl-N(1)-(5-
CC       phospho-D-ribosyl)glycinamide: step 1/2. {ECO:0000255|HAMAP-
CC       Rule:MF_00419}.
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_00419}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00419}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the FGAMS family.
CC       {ECO:0000255|HAMAP-Rule:MF_00419}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE004091; AAG07150.1; -; Genomic_DNA.
DR   PIR; B83175; B83175.
DR   RefSeq; NP_252452.1; NC_002516.2.
DR   RefSeq; WP_003113821.1; NZ_QZGE01000001.1.
DR   SMR; Q9HXN2; -.
DR   PaxDb; Q9HXN2; -.
DR   PRIDE; Q9HXN2; -.
DR   EnsemblBacteria; AAG07150; AAG07150; PA3763.
DR   GeneID; 879752; -.
DR   KEGG; pae:PA3763; -.
DR   PATRIC; fig|208964.12.peg.3938; -.
DR   PseudoCAP; PA3763; -.
DR   HOGENOM; CLU_001031_0_2_6; -.
DR   InParanoid; Q9HXN2; -.
DR   OMA; LSANWMW; -.
DR   PhylomeDB; Q9HXN2; -.
DR   BioCyc; PAER208964:G1FZ6-3834-MONOMER; -.
DR   UniPathway; UPA00074; UER00128.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004642; F:phosphoribosylformylglycinamidine synthase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.1330.10; -; 2.
DR   Gene3D; 3.40.50.880; -; 1.
DR   Gene3D; 3.90.650.10; -; 2.
DR   HAMAP; MF_00419; PurL_1; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR040707; FGAR-AT_N.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR010073; PurL_large.
DR   InterPro; IPR041609; PurL_linker.
DR   InterPro; IPR010918; PurM-like_C_dom.
DR   InterPro; IPR036676; PurM-like_C_sf.
DR   InterPro; IPR036921; PurM-like_N_sf.
DR   InterPro; IPR036604; PurS-like_sf.
DR   Pfam; PF02769; AIRS_C; 2.
DR   Pfam; PF18072; FGAR-AT_linker; 1.
DR   Pfam; PF18076; FGAR-AT_N; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   SUPFAM; SSF55326; SSF55326; 2.
DR   SUPFAM; SSF56042; SSF56042; 2.
DR   SUPFAM; SSF82697; SSF82697; 1.
DR   TIGRFAMs; TIGR01735; FGAM_synt; 1.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Cytoplasm; Glutamine amidotransferase; Ligase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Purine biosynthesis; Reference proteome.
FT   CHAIN           1..1298
FT                   /note="Phosphoribosylformylglycinamidine synthase"
FT                   /id="PRO_0000100413"
FT   DOMAIN          1045..1298
FT                   /note="Glutamine amidotransferase type-1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00419"
FT   NP_BIND         305..316
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00419"
FT   NP_BIND         384..386
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00419"
FT   ACT_SITE        1138
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00419"
FT   ACT_SITE        1263
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00419"
FT   ACT_SITE        1265
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00419"
FT   METAL           677
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00419"
FT   METAL           716
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00419"
FT   METAL           720
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00419"
FT   METAL           884
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00419"
FT   BINDING         676
FT                   /note="ATP; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00419"
FT   BINDING         886
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00419"
SQ   SEQUENCE   1298 AA;  140647 MW;  95BBE47CCA4FE8D1 CRC64;
     MLILRGAPAL SAFRHGKLLE QLTQHVPAVT GLYAEFAHFA DVTGALTADE EQVLARLLKY
     GPSVPVQEPS GRLFLVVPRF GTISPWSSKA SDIARNCGLA KIDRLERGIA YYVQGELSES
     DAQQVAARLH DRMTQLVLDR LEGAAELFSH AQPRPLTAVD VLGGGRAALE KANVELGLAL
     AEDEIDYLLK SFGELGRNPH DVELMMFAQA NSEHCRHKIF NASWDIDGQA QDKSLFGMIK
     NTYEMNREGV LSAYKDNAAV IVGHVAGRFF PDPQTREYAA SREPVQILMK VETHNHPTAI
     APFPGASTGS GGEIRDEGAT GRGAKPKAGL TGFTVSNLQI PGFEQPWEVP YGKPERIVTA
     LDIMVEGPLG GAAFNNEFGR PALTGYFRTF EQKIATPHGE EVRGYHKPIM LAGGMGNIRD
     EHVQKGEISV GAKLIVLGGP AMLIGLGGGA ASSMATGASS ADLDFASVQR DNPEMERRCQ
     EVIDRCWQLG ERNPISFIHD VGAGGLSNAL PELINDGGRG GRFELRAVPN DEPGMSPLEI
     WCNESQERYV LSVDAADFET FKAICERERC PFAVVGEAIE QRQLTVADSH FDNKPVDMPL
     EVLLGKAPRM HRAVTREAEL GDDFDAAGLE LQESVERVLR HPAVASKSFL ITIGDRTITG
     LVARDQMVGP WQVPVADCAV TATSFDVYTG EAMAMGERTP LALLDAPASG RMAIGETVTN
     LAAARVGKLS DIKLSANWMA AAGHPGEDAR LYDTVKAVGM ELCPELGITI PVGKDSMSMK
     TRWQDNGEDK SVTSPVSLIV TGFAPVADVR QSLTPQLRLD KGETDLILID LGRGKNRLGG
     SILAQVHGKL GRAVPDVDDA EDLKAFFAVI QGLNADGHIL AYHDRSDGGL ITSVLEMAFA
     GHCGVELNLD ALADSREELA AVLFSEELGA VIQVREGATP EVLAQFSAAG LDDCVAVIGQ
     PVNGYEINLN YNGETVYSAQ RRILQRIWSE TSYQIQRLRD NADCAEQEFD ALLDEDNPGL
     SIKLSYDVND DIAAPYIKKG VRPKVAILRE QGVNGQVEMA AAFDRAGFAA IDVHMSDILA
     GRVDLDAFKG LVACGGFSYG DVLGAGEGWA KSILFNARAR DGFQAFFARK DSFALGVCNG
     CQMMSNLHEL IPGTEFWPHF VRNRSEQFEA RVAMVQVQES SSIFLQGMAG SRLPIAIAHG
     EGHAEFESEE ALLEADLSGC VSLRFVDNHG KVTEAYPANP NGSPRGITGL SSRDGRVTIM
     MPHPERVFRA VQNSWRPDDW QEDGGWLRMF RNARVWVD
//
